Skip to main content
. 2022 Aug 6;10(22):7859–7871. doi: 10.12998/wjcc.v10.i22.7859

Figure 4.

Figure 4

Ranking of treatment strategies based on probability of prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with the cumulative ranking area. A: Incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP); B: Mild PEP; C: Moderate-to-severe PEP.